Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Herophilus Announces Results from Research Collaboration with Cerevel Therapeutics to Evaluate Novel Neuroimmune Modulating Therapeutic Strategies for Schizophrenia
Herophilus announced today the publication of “Neuroimmune Cortical Organoids Overexpressing C4A Exhibit Multiple Schizophrenia Endophenotypes” […]
CytoSMART Technologies Joins the Axion BioSystems Brand
Axion BioSystems, a leader in live-cell analysis tools, today announced the full integration of imaging […]
Akston Biosciences Strengthens Board with Addition of John T. Preston
Akston Biosciences Corporation, a clinical-stage biotechnology company, today announced that John Preston, a founder of […]
AmerisourceBergen Kicks Off Strategic Relationship with Civica
Starting today, global healthcare company AmerisourceBergen will serve as an exclusive distribution partner and provide […]
Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors
Gandeeva Therapeutics, a biotechnology company focused on designing and developing precision therapeutics guided by cryogenic […]
Thermo Fisher Scientific Launches CE-IVD Marked Assay to Detect Treatment-Resistant Strains of HIV-1
Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its […]
CHOP Researchers Develop Tool that Reduces Errors in Stem Cell Transplant Reporting
Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a custom-built application to automate determination […]
Memo Therapeutics AG Announces Positive Phase I Data with AntiBKV for Treatment of BKV Infection
Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced today […]
ADARx Pharmaceuticals Raises $46 Million in Financing as Lead Product Enters the Clinic
ADARx Pharmaceuticals, a clinical-stage biotechnology company developing RNA-targeting therapeutics, has announced the close of a […]
Immunyx Pharma Selected to Join BLUE KNIGHT
Immunyx Pharma, a developer of immune modulating therapies for neutrophil-based diseases, announced it has been […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more